arsenic trioxide has been researched along with Neoplasm Metastasis in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (55.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, KJ; Jin, YX; Li, B; Yang, MH; Zhao, XW; Zheng, JC | 1 |
| Alimoghaddam, K; Ghaffari, SH; Ghanizadeh-Vesali, S; Ghavamzadeh, A; Mojarrad, M; Yousefi, M; Zekri, A | 1 |
| Fang, ZT; Li, S; Liu, R; Qian, S; Qu, XD; Wang, GZ; Wang, JH; Wang, LL; Yang, GW; Yang, MJ; Zhang, W; Zhang, WS; Zhu, L | 1 |
| Chen, K; Huang, H; Li, B; Xie, SL; Yang, MH; Zang, YS; Zhao, XW | 1 |
| Jiang, Z; Tang, J; Wang, C | 1 |
| Ally, MS; Atwood, SX; Bailey-Healy, I; Beachy, PA; Chang, AL; Colevas, AD; Kim, J; Oro, A; Ransohoff, K; Rezaee, M; Sarin, K; Tang, JY | 1 |
| Cao, Z; Chen, X; Cui, L; Gao, B; Zhang, S; Zhang, W | 1 |
| Chan, R; Evers, BM; Feddock, JM; Johnson, SE; Jyoti, A; Napier, D; O'Halloran, TV; Sethi, P; Swindell, EP; Upreti, M; Weiss, HL | 1 |
| Bao, X; Guo, W; Huang, Y; Liu, K; Ren, T; Wang, S; Zhang, F; Zheng, B | 1 |
| Gao, Q; Krebsbach, PH; Kumar, P; Ning, Y; Polverini, PJ; Wang, Z | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Motzer, RJ; Schwartz, L; Vuky, J; Yu, R | 1 |
| Huang, SG; Jiang, S; Kong, BH; Yang, RF | 1 |
| Huang, SG; Jiang, S; Kong, BH; Ma, YY | 1 |
| Hori, S; Kakehi, Y; Kakizuka, A; Maeda, H; Ogawa, O; Ohizumi, H; Segawa, T | 1 |
| Chen, JY; Du, CW; Hong, CQ; Hong, X; Li, DR; Lin, YC; Lin, ZZ; Peng, X; Wen, BG; Wu, MY; Xie, LX; Zhang, H | 1 |
| Ardalan, B; Lima, M; Subbarayan, PR | 1 |
| Fu, M; Li, Y; Liang, X; Lin, C; Qian, H; Wang, Y; Yu, J; Zhang, X | 1 |
| Bismar, TA; Diaz, Z; Laurenzana, A; Mann, KK; Miller, WH; Schipper, HM | 1 |
| Hori, S; Ichijo, H; Kakehi, Y; Kakizuka, A; Maeda, H; Nishitoh, H; Ogawa, O | 1 |
2 trial(s) available for arsenic trioxide and Neoplasm Metastasis
| Article | Year |
|---|---|
Phase II trial of arsenic trioxide in patients with metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Karnofsky Performance Status; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Oxides; Tomography, X-Ray Computed | 2002 |
Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: a clinical experience.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Colorectal Neoplasms; DNA Primers; Gene Expression Regulation; Humans; Middle Aged; Neoplasm Metastasis; Oxides; Thymidylate Synthase; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
18 other study(ies) available for arsenic trioxide and Neoplasm Metastasis
| Article | Year |
|---|---|
Arsenic Trioxide Inhibits the Metastasis of Small Cell Lung Cancer by Blocking Calcineurin-Nuclear Factor of Activated T Cells (NFAT) Signaling.
Topics: Animals; Arsenic Trioxide; Calcineurin; Cell Movement; Cell Proliferation; China; DNA-Binding Proteins; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Nude; Muscle Proteins; Neoplasm Metastasis; Neovascularization, Pathologic; NFATC Transcription Factors; Receptors, CXCR; rho GTP-Binding Proteins; Signal Transduction; Small Cell Lung Carcinoma; Up-Regulation; Vascular Endothelial Growth Factor A | 2019 |
Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Autocrine Communication; Breast Neoplasms; Cell Line, Transformed; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Human Growth Hormone; Humans; Matrix Metalloproteinases; MCF-7 Cells; Models, Biological; Neoplasm Metastasis; Oxides; Proteolysis; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; RNA, Messenger; Transcription, Genetic; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2013 |
Arsenic trioxide: marked suppression of tumor metastasis potential by inhibiting the transcription factor Twist in vivo and in vitro.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Embolization, Therapeutic; Liver Neoplasms; Lung Neoplasms; Male; Neoplasm Metastasis; Oxides; Rats; Rats, Inbred BUF; Twist-Related Protein 1 | 2014 |
Efficacy of Arsenic Trioxide in the Treatment of Malignant Pleural Effusion Caused by Pleural Metastasis of Lung Cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Microvessels; Neoplasm Metastasis; NF-kappa B; Oxides; Permeability; Pleural Effusion, Malignant; Tumor Burden; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2015 |
[The expression of AQP9 in HepG2 cells affects cell biological behaviors and sensitivity to As2O3].
Topics: Antineoplastic Agents; Apoptosis; Aquaporins; Arsenic Trioxide; Arsenicals; Caspase 3; Cell Cycle; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Molecular Targeted Therapy; Neoplasm Invasiveness; Neoplasm Metastasis; Oxides; Transfection | 2015 |
Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Basal Cell; Drug Resistance, Neoplasm; Follow-Up Studies; Hedgehog Proteins; Humans; Itraconazole; Male; Middle Aged; Neoplasm Metastasis; Oxides; RNA, Messenger; Skin Neoplasms; Transcription Factors; Treatment Outcome; Zinc Finger Protein GLI1 | 2016 |
Downregulation of B7-H4 in the MHCC97-H hepatocellular carcinoma cell line by arsenic trioxide.
Topics: Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Liver Neoplasms; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Oxides; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; V-Set Domain-Containing T-Cell Activation Inhibitor 1; Vascular Endothelial Growth Factor A | 2016 |
Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cells, Cultured; Chemoradiotherapy; Cisplatin; Female; Galectin 1; Human Umbilical Vein Endothelial Cells; Humans; Mesenchymal Stem Cells; Mice; Mice, Nude; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Oxides; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays; Young Adult | 2016 |
Induction of the mesenchymal to epithelial transition by demethylation-activated microRNA-125b is involved in the anti-migration/invasion effects of arsenic trioxide on human chondrosarcoma.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Chondrosarcoma; DNA Demethylation; Down-Regulation; Epigenesis, Genetic; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Oxides; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2016 |
Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone.
Topics: Animals; Arsenic Trioxide; Arsenicals; Bone and Bones; Bone Resorption; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Mouth Neoplasms; Neoplasm Metastasis; Neovascularization, Pathologic; Osteoblasts; Oxides; Radiation, Ionizing; Treatment Outcome; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A | 2008 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
[Primary study of arsenic trioxide inhibits abdomino-metastatic tumor formation of human ovarian carcinoma in nude mice and its mechanisms].
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Disease Models, Animal; Fas Ligand Protein; fas Receptor; Female; Humans; Membrane Glycoproteins; Mice; Mice, Nude; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Oxides; Transcription Factors; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2002 |
[Impact of arsenic trioxide on proliferation and metastasis of drug-resistant human ovarian carcinoma cell line].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Division; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; fas Receptor; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylases; Humans; Microscopy, Electron; Monomeric GTP-Binding Proteins; Neoplasm Metastasis; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Diphosphate Kinase; Ovarian Neoplasms; Oxides; Proteins; Proto-Oncogene Proteins c-myc; Repressor Proteins; Time Factors; Trans-Activators; Transcription Factors; Tumor Cells, Cultured | 2002 |
Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Glutathione; HeLa Cells; Humans; Hydrogen Peroxide; Male; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oxides; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Xenograft Model Antitumor Assays | 2004 |
Arsenic trioxide reduces the invasive and metastatic properties of nasopharyngeal carcinoma cells in vitro.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; Microscopy, Confocal; Nasopharyngeal Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Oxides; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Viral Matrix Proteins | 2006 |
Arsenic trioxide (As2O3) reduces the invasive and metastatic properties of cervical cancer cells in vitro and in vivo.
Topics: Animals; Arsenic Trioxide; Arsenicals; beta Catenin; Cadherins; Caveolin 1; Cell Adhesion; Cell Line, Tumor; Cell Movement; Female; Growth Inhibitors; HeLa Cells; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B; Oxides; Uterine Cervical Neoplasms | 2007 |
Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Chromans; Cytochromes c; Drug Synergism; Humans; Liver; Lymphoma; Membrane Potential, Mitochondrial; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Oxides | 2007 |
Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cell Death; Cell Division; Dose-Response Relationship, Drug; Enzyme Activation; Humans; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred BALB C; Mice, SCID; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neoplasm Transplantation; Neoplastic Stem Cells; Oxides; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Reactive Oxygen Species; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2001 |